In less than a fortnight, some cancer medicines in India will cost a fraction of what they do today. One brand of palbociclib capsules, now priced at Rs 40,421, will sell for Rs 2,720. A thiotepa injection priced at Rs 80,072 will cost Rs 7,150.
However, for the newer medicines that many patients now depend on, the price list brings almost no relief. Sample this: A pack of 30 osimertinib tablets, used in lung cancer, costs Rs 4.16 lakh today and will cost the same after November 9.